Noctrix Health Raises $33.5M and Expands Leadership Team to Accelerate U.S. Commercialization of Nidra(R) Therapy for Restless Legs Syndrome (RLS)

Previous
Previous

HealthEdge and UST HealthProof Merge, Creating Disruptive AI-Powered, Healthcare Payer Technology and Services Leader

Next
Next

Tuesday Health Locked Up $60 Million Strategic Investment